Published in Diabetologia on November 01, 1996
Assessing the evidence on aspirin in diabetes mellitus. Gemini or Libra; lumping or splitting; surrogate or hard; low or high; interventionist or nihilist. Diabetologia (1996) 0.96
Aspirin therapy in diabetes mellitus. Diabetologia (1997) 0.75
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain. BMC Fam Pract (2007) 0.75
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia (2001) 2.15
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemost (1994) 2.03
Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care (1998) 1.24
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest (1998) 1.21
The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med (2004) 1.19
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res (1998) 1.08
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism (1999) 1.08
Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia (1996) 0.99
Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia (2005) 0.93
Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care (1997) 0.92
Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes (1995) 0.91
Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism (1996) 0.83
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care (1997) 0.81
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Invest (2001) 0.80
Hyperglycemia counterbalances the antihypertensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J Diabetes Complications (1997) 0.80
Serum myoglobin in primary hypothyroidism and effect of L-thyroxine therapy. J Nucl Med (1982) 0.77
Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes (1994) 0.77
Intra-arterial iloprost for limb ischaemia. Lancet (1995) 0.76
Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care (1999) 0.76
Effect of intensive glycaemic control on fibrinogen plasma concentrations in patients with Type II diabetes mellitus. Relation with beta-fibrinogen genotype. Diabetologia (1998) 0.76
Serum tissue polypeptide antigen (TPA) in thyroid cancer. J Endocrinol Invest (1984) 0.75
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? Diabetes Care (1999) 0.75
Hypertension and ascorbic acid. Lancet (2000) 0.75
Concomitant primary hyperparathyroidism, Graves' disease and vitamin D deficiency. Acta Otorhinolaryngol Ital (2003) 0.75